Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma

Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma

BACKGROUND: Hodgkin's lymphoma has high rates of cure, but in 15% to 20% of general patients and between 35% and 40% of those in advanced stages, the disease will progress or will relapse after initial treatment. For this group, hematopoietic stem cell transplantation is considered one option o...

Full description

Bibliographic Details
Main Authors: Afonso José Pereira Cortez, Frederico Luiz Dulley, Rosaura Saboya, Alfredo Mendrone Júnior, Ulisses Amigo Filho, Fabio Luiz Coracin, Valéria Buccheri, Camila da Cruz Gouveia Linardi, Milton Artur Ruiz, Dalton de Alencar Fischer Chamone
Format: Article
Language:English
Published: Elsevier 2011-02-01
Series:Revista Brasileira de Hematologia e Hemoterapia
Subjects:
Hodgkin's lymphoma
Hematopoietic stem cell transplantation
Autologous transplantation
Doxorubicin
Bleomycynm
Vinblastine
Dacarbazine
Study retrospective
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000100007

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000100007

Similar Items